These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7838244)

  • 21. Therapy of lupus nephritis. A two-year prospective study.
    Doria A; Piccoli A; Vesco P; Vaccaro E; Marson P; De Silvestro G; Ossi E; Gambari P
    Ann Med Interne (Paris); 1994; 145(5):307-11. PubMed ID: 7985937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
    Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
    Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT
    Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of immunosuppressive drugs in lupus nephritis].
    Klippel JH; Austin HA; Balow JE
    Ter Arkh; 1986; 58(7):109-11. PubMed ID: 2945277
    [No Abstract]   [Full Text] [Related]  

  • 28. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
    Barbano G; Gusmano R; Damasio B; Alpigiani MG; Buoncompagni A; Gattorno M; Perfumo F
    J Nephrol; 2002; 15(2):123-9. PubMed ID: 12018627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The course and treatment of lupus nephritis.
    Appel GB; Valeri A
    Annu Rev Med; 1994; 45():525-37. PubMed ID: 8198400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of treatment in lupus nephritis: effects of prednisone.
    Pollak VE; Dosekun AK
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):170-7. PubMed ID: 7102665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of lupus nephritis: a meta-analysis of clinical trials.
    Bansal VK; Beto JA
    Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of proliferative lupus nephritis--a critical approach.
    Buhaescu I; Covic A; Deray G
    Semin Arthritis Rheum; 2007 Feb; 36(4):224-37. PubMed ID: 17067659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
    Steinberg AD; Steinberg SC
    Arthritis Rheum; 1991 Aug; 34(8):945-50. PubMed ID: 1859488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of diffuse proliferative lupus nephritis: an Indian experience.
    Abraham MA; Korula A; Arun KN; Jayakrishnan K; John GT; Thomas PP; Jacob CK
    Natl Med J India; 1997; 10(6):273-5. PubMed ID: 9481097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longterm followup of childhood lupus nephritis.
    Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.